A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Pfizer
Pfizer
iOnctura
University Hospital, Angers
Essen Biotech
Ipsen
Massive Bio, Inc.
Immunitas Therapeutics
Hvivo
Ipsen
Cyteir Therapeutics, Inc.
Celldex Therapeutics
NovalGen Ltd.
Eastern Cooperative Oncology Group
Seagen Inc.
Opna Bio LLC
GlaxoSmithKline
Pfizer
University of Wisconsin, Madison
National Institutes of Health Clinical Center (CC)
GlaxoSmithKline
European Organisation for Research and Treatment of Cancer - EORTC
Wake Forest University Health Sciences
Rutgers, The State University of New Jersey
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Scripps Health
Case Comprehensive Cancer Center